Company Overview and News

 
Castillo Copper’s rock chip results confirm polymetallic potential at Broken Hill project

2018-09-28 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has revealed rock-chip results assaying up to 1,440 ppm cobalt and 23,700 ppm copper within the Area 1 prospect at its Broken Hill project in New South Wales.
CCZ

 
Castillo Copper downhole surveys target additional massive sulphides

2018-09-23 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) is progressing downhole electromagnetic (DHEM) surveys aimed at detecting massive sulphide targets within its Cangai Copper Project in northern New South Wales.
CCZ

 
Cobalt 27: Don't Forget The Nickel Exposure

2018-09-19 seekingalpha
This article was first published on Trend Investing on September 13; therefore, all data is as of that date.
CLA FT PSDNF AYR CCZ HAV AEOMF CZI KATFF POS HIG AUZ RNX KAT FTMDF GME CNJ HLPCF CSSQF AQR

 
Castillo Copper approaching 'critical 12 months' - Capital Network analyst

2018-09-12 proactiveinvestors.com.au
The flagship project consists of three prospects at Jackaderry in NSW, Australia which are highly prospective for Copper-Cobalt-Zinc.
CCZ

 
Castillo Copper sampling infers extended mineralisation at Cangai Copper Project

2018-09-10 proactiveinvestors.com.au
Castillo Copper Ltd’s (ASX:CCZ) soil and rock-chip samples have inferred that mineralisation extends from the eastern end of the line of lode at Cangai Copper Project in northern New South Wales.
CCZ

 
Castillo Copper confirms 'very exceptional results, very high grade mineralisation'

2018-09-05 proactiveinvestors.com.au
The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
CCZ

 
Castillo Copper confirms 'very exceptional results, very high grade mineralisation'

2018-09-05 proactiveinvestors.com.au
Alan Armstrong, executive director of Castillo Copper Ltd (ASX:CCZ), speaks to Proactive Investors about the first batch of assay results received from five holes of an ongoing 39-hole drill program on the Cangai Copper Mine project in NSW, Australia.
CCZ

 
Castillo Copper confirms 'very exceptional results, very high grade mineralisation'

2018-09-05 proactiveinvestors.com.au
Alan Armstrong, executive director of Castillo Copper Ltd (ASX:CCZ), speaks to Proactive Investors about the first batch of assay results received from five holes of an ongoing 39-hole drill program on the Cangai Copper Mine project in NSW, Australia.
CCZ

 
Castillo Copper’s first batch of assays reveal 10.25% copper at Cangai

2018-09-02 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has received assays from the first five drill holes of its 39-hole program at the Cangai Copper Mine in New South Wales.
CCZ

15
Cobalt Miners News For The Month Of August 2018

2018-08-23 seekingalpha
Cobalt miner news - BHP seeking to add cobalt sulphate from Nickel West operation. China Molybdenum net profit set to surge between 271.21% and 295.16%.
SIE PIO CLA PANRF BLT CCZ PAN HAV MCR KBGCF CTM AXE ECSIF IGO VIC BAR AOU HIG PCRCF PLM.RT SNNAF FQM MCRZF BXTMF MLX PSDNF POM AYR CDU RGARF CHK MCRZY FTMDF KAT RER BBL CSSQF BHPLF GMRSF CZN PGM GBLEF NZRIF AZS GLCNF DLE HBNRF MEI PIONF GAL CZI AMSLF BPLNF HMI POS AUZ RNX GME FQVLF AQR PTNUF FT BHPBF HNLMF ORR CDNMD 3993 UMICY CDNMF IIDDY AEOMF USCFF FTSSF KATFF BBBMF MLXEF OZMLF PLM BHP CNJ AZRMF HLPCF BPL BHP OZL ARV

 
Castillo Copper seeing 'extraordinary results very early on' from drilling at Cangai Project

2018-08-23 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) executive director Alan Armstrong speaks to Proactive Investors about progress on the ground at the NSW Jackaderry Project, which includes the historic Cangai Copper Mine.
CCZ

 
Castillo Copper strikes shallow massive sulphides in first holes of new drilling at Cangai project

2018-08-20 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has struck success with the first few holes of its phase II drilling campaign at the Cangai Copper Project intersecting shallow, highly mineralised massive sulphide.
CCZ

 
Castillo Copper has trading halt extended by ASX pending drill results

2018-08-20 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) has had its trading halt extended by the ASX pending drilling results from the Cangai Copper Project in northeast New South Wales.
CCZ

 
Castillo Copper awaits drill results from Cangai project, granted trading halt

2018-08-16 proactiveinvestors.com.au
Castillo Copper Ltd (ASX:CCZ) is awaiting an exploration update from drilling at its Cangai Copper Project in northern New South Wales and has been granted a trading halt by the ASX.
CCZ

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:CCZ / CASTILLO COPPER LIMITED on message board site Silicon Investor.

CCZ - COMMERCIAL CONSOLIDATORS - Company Website http://comm CCZ - COMMERCIAL CONSOLIDATORS - Company Website http://comm CCZ - COMMERCIAL CONSOLIDATORS - Company Website http://comm CASTELLO CASINO CORP. (CCCZ/CSTC) CASTELLO CASINO CORP. (CCCZ/CSTC) CASTELLO CASINO CORP. (CCCZ/CSTC)